BOSTON--(BUSINESS WIRE)--May 12, 2015--
Verastem, Inc. (NASDAQ: VSTM), focused on discovering and developing
drugs to treat cancer by the targeted killing of cancer stem cells,
today announced that the company will present at the 2015 UBS Global
Healthcare Conference on Tuesday, May 19 at 1:30 p.m. ET at the Sheraton
New York Times Square Hotel in New York City.
A live webcast of the presentation will be available on the company's
website at http://phx.corporate-ir.net/phoenix.zhtml?c=250749&p=irol-calendar.
An archived presentation will be available for 90 days.
About Verastem, Inc.
Verastem, Inc. (NASDAQ:VSTM) is discovering and developing drugs to
treat cancer by the targeted killing of cancer stem cells. Cancer stem
cells are an underlying cause of tumor recurrence and metastasis.
Verastem is developing small molecule inhibitors of signaling pathways
that are critical to cancer stem cell survival and proliferation: FAK
and PI3K/mTOR. For more information, please visit www.verastem.com.
Source: Verastem, Inc.
Brian Sullivan, 781-292-4214